Menu
Medical Condition
Orthopedics & Traumatology
Orthopedics & Traumatology ICD-10: A18.01

Tuberculosis of Bone, Right Knee

Standardized diagnosis for Tuberculosis of Bone, Right Knee.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

EN: Patient presents with a chronic, progressive history of right knee pain, localized swelling, and restricted range of motion. Symptoms are associated with constitutional signs including low-grade evening fevers, night sweats, and unintentional weight loss. No history of recent trauma. Patient reports morning stiffness and progressive antalgic gait. AR: يعاني المريض من تاريخ مرضي مزمن وتدريجي لألم في الركبة اليمنى، مع تورم موضعي ومحدودية في نطاق الحركة. الأعراض مصحوبة بعلامات جهازية تشمل حمى خفيفة مسائية، تعرق ليلي، وفقدان وزن غير مبرر. لا يوجد تاريخ لإصابة حديثة. يشتكي المريض من تيبس صباحي وصعوبة متزايدة في المشي.

General Examination

EN: Right knee examination reveals fusiform swelling, synovial thickening, and localized warmth without erythema. Tenderness noted along the joint line. Range of motion is significantly limited by pain and muscle spasm. Atrophy of the quadriceps muscle is evident. Distal neurovascular status is intact. No palpable popliteal lymphadenopathy. AR: كشف فحص الركبة اليمنى عن تورم مغزلي، سماكة في الغشاء الزلالي، وسخونة موضعية بدون احمرار. يوجد إيلام عند الضغط على خط المفصل. نطاق الحركة محدود بشكل كبير بسبب الألم والتشنج العضلي. لوحظ وجود ضمور في العضلة الرباعية. الحالة العصبية والوعائية للطرف سليمة. لا يوجد تضخم محسوس في الغدد الليمفاوية المأبضية.

Treatment Protocol

EN: Initiate multi-drug antitubercular chemotherapy (RIPE regimen: Rifampin, Isoniazid, Pyrazinamide, Ethambutol) for the prescribed duration. Immobilization of the right knee via splinting or bracing to prevent deformity. Monitor liver function tests and visual acuity periodically. Surgical consultation for potential synovial biopsy, debridement, or joint stabilization if indicated. AR: البدء في العلاج الكيميائي المضاد للسل متعدد الأدوية (بروتوكول RIPE: ريفامبين، أيزونيازيد، بيرازيناميد، إيثامبوتول) للمدة المحددة. تثبيت الركبة اليمنى باستخدام جبيرة أو دعامة لمنع التشوه. مراقبة وظائف الكبد وقوة الإبصار بشكل دوري. استشارة جراحية لتقييم الحاجة لأخذ خزعة من الغشاء الزلالي، أو التنضير الجراحي، أو تثبيت المفصل إذا لزم الأمر.

Patient Education

EN: Tuberculosis of the bone is a serious infection requiring strict adherence to a long-term medication regimen. Do not discontinue antibiotics even if symptoms improve. Maintain a nutritious diet and ensure adequate rest. Report any side effects such as jaundice, vision changes, or numbness immediately. Regular follow-up appointments are mandatory to monitor treatment response and prevent joint damage. AR: سل العظام عدوى خطيرة تتطلب التزاماً صارماً ببرنامج العلاج الدوائي طويل الأمد. لا تتوقف عن تناول المضادات الحيوية حتى لو تحسنت الأعراض. حافظ على نظام غذائي مغذٍ واحصل على قسط كافٍ من الراحة. أبلغ الطبيب فوراً عن أي آثار جانبية مثل اليرقان (اصفرار العين)، تغيرات في الرؤية، أو تنميل. المتابعة الدورية إلزامية لمراقبة الاستجابة للعلاج ومنع حدوث تلف دائم في المفصل.

Systemic & Specialized Examinations

Neurological

EN: Distal neurovascular status intact globally. AR: الحالة العصبية والوعائية الطرفية سليمة تماماً.

Orthopedic & Trauma Assessments

Mechanism of Injury

EN: Insidious degenerative wear and tear. No acute trauma. AR: تآكل تنكسي تدريجي. لا توجد صدمة حادة.

Gait & Posture

EN: Antalgic gait. Reduced stance phase on the affected side. Trendelenburg or varus thrust may be present. AR: مشية متألمة. قصر في مرحلة الوقوف على الجانب المصاب. قد يوجد اندفاع تقوسي أو علامة ترندلينبورغ.

Local Examination

EN: Moderate chronic joint effusion/thickening. Obvious malalignment in the coronal plane. Mild surrounding muscle atrophy. AR: انصباب/تسمك مفصلي مزمن. سوء محاذاة واضح. ضمور خفيف في العضلات المحيطة.

Special Tests

EN: Grind tests (Patellar/FABER) strongly positive. Ligament tests negative. AR: اختبارات الطحن (مثل FABER) إيجابية بقوة. اختبارات الأربطة سلبية.

Motor Power

EN: 4/5 strength in proximal muscles due to pain inhibition. Distal strength 5/5. AR: قوة 4/5 في العضلات القريبة بسبب تثبيط الألم. القوة الطرفية 5/5.

Sensory Profile

EN: Sensation intact to light touch in all dermatomes. AR: الإحساس سليم للمس الخفيف في جميع التوزيعات العصبية.

Reflexes

EN: 2+ symmetric deep tendon reflexes. AR: المنعكسات العميقة 2+ ومتماثلة.

Peripheral Pulses

EN: DP and PT pulses 2+ bounding. Capillary refill < 2 seconds. AR: نبضات القدم 2+ قوية. عودة امتلاء الشعيرات < ثانيتين.

Comprehensive Clinical Guide: Tuberculosis of the Bone (Skeletal TB), Right Knee

1. Introduction and Overview

Skeletal tuberculosis (TB), also known as osteoarticular tuberculosis, represents a chronic, progressive, and potentially destructive infectious process caused by Mycobacterium tuberculosis. While the pulmonary system is the primary port of entry, the skeletal system remains the most common site of extrapulmonary manifestation. Tuberculosis of the right knee—a form of tuberculous arthritis—is a debilitating condition that requires early diagnosis and aggressive multi-drug therapy to prevent irreversible joint destruction, permanent deformity, and chronic disability.

The knee joint is a weight-bearing, synovial-lined joint, making it particularly susceptible to hematogenous seeding of the tubercle bacillus. In clinical practice, the management of knee TB necessitates a multidisciplinary approach involving orthopedists, infectious disease specialists, and physiotherapists to restore function and mitigate the severe sequelae associated with delayed intervention.


2. Etiology and Pathophysiology

The Infectious Agent

The causative organism is Mycobacterium tuberculosis, an acid-fast bacillus. In the context of bone and joint TB, the infection is almost always secondary to a primary focus elsewhere, usually the lungs, lymph nodes, or genitourinary tract, even if the primary site is clinically quiescent or radiographically occult.

Pathophysiological Mechanism

The pathogenesis of right knee TB follows a distinct sequence:
1. Hematogenous Seeding: The bacillus enters the bloodstream from a primary focus and lodges in the synovial membrane or the subchondral bone of the distal femur or proximal tibia.
2. Synovial Proliferation: The bacilli induce a chronic inflammatory response in the synovium, leading to the formation of "pannus"—a vascular, inflammatory tissue that spreads over the articular cartilage.
3. Cartilage Erosion: The pannus secretes proteolytic enzymes and cytokines (notably TNF-alpha) that degrade the cartilage, leading to irreversible joint space narrowing.
4. Caseous Necrosis: As the infection progresses, the formation of granulomas with central caseous necrosis occurs, potentially leading to cold abscesses that may track toward the skin, forming sinuses.
5. Bone Destruction: Osteoclast activation, stimulated by the inflammatory milieu, leads to bone resorption, sequestrum formation, and eventual joint ankylosis.


3. Clinical Staging and Grading

To standardize treatment, clinicians often utilize the Pott’s classification or functional grading systems for tuberculous arthritis of the knee.

Stage Clinical/Radiographic Features
Stage I Synovial thickening, minimal effusion, no significant bone destruction.
Stage II Early articular cartilage destruction, periarticular osteoporosis, joint space narrowing.
Stage III Advanced destruction, bone sequestra, cystic changes, subluxation/dislocation.
Stage IV Fibrous or bony ankylosis, severe joint deformity, sinus tract formation.

4. Standard Clinical Presentation

Patients presenting with TB of the right knee rarely exhibit systemic symptoms like night sweats or weight loss in the early stages. The clinical presentation is typically insidious.

Key Symptoms

  • Pain: Dull, aching pain that worsens with activity and weight-bearing.
  • Swelling: Persistent, "doughy" swelling of the knee joint due to synovial hypertrophy and effusion.
  • Limitation of Motion: Stiffness, particularly in the morning, which gradually progresses to a fixed flexion deformity.
  • Muscle Wasting: Significant quadriceps atrophy is a hallmark sign of chronic knee joint pathology.
  • Systemic Symptoms: Low-grade evening pyrexia, malaise, and night sweats (seen in advanced or disseminated cases).

5. Differential Diagnosis

Distinguishing knee TB from other pathologies is critical, as misdiagnosis leads to inappropriate corticosteroid use, which can exacerbate the TB infection.

  • Septic Arthritis (Pyogenic): Usually presents with acute onset, high fever, and severe pain. TB is chronic and indolent.
  • Rheumatoid Arthritis (RA): Typically polyarticular and bilateral. TB of the knee is almost exclusively monoarticular.
  • Pigmented Villonodular Synovitis (PVNS): Mimics the swelling but lacks the systemic inflammatory markers of TB.
  • Fungal Arthritis: Rare, but can mimic the clinical and radiographic features of TB.
  • Traumatic Hemarthrosis: History of injury is key; however, chronic cases may mimic TB.

6. Key Diagnostic Tests

A systematic diagnostic workup is mandatory for definitive confirmation.

Imaging Modalities

  • Plain Radiographs: Early stages show soft tissue swelling and periarticular osteoporosis (Phemister’s Triad: juxta-articular osteoporosis, peripheral osseous erosions, and gradual narrowing of the joint space).
  • MRI (Gold Standard): Provides superior visualization of synovial thickening, early cartilage loss, bone marrow edema, and subchondral abscesses (Brodie’s abscess).
  • CT Scan: Used primarily to assess the extent of bone sequestration and destruction before surgical intervention.

Laboratory Investigations

  • ESR/CRP: Usually elevated, serving as a marker for disease activity and treatment response.
  • Mantoux Test / IGRA: Supportive but not diagnostic in endemic regions.
  • Synovial Fluid Analysis: The most definitive diagnostic tool. It typically shows high protein, low glucose, and moderate pleocytosis (lymphocytic predominance).
  • Biopsy (Synovial/Bone): Histopathology demonstrating caseating granulomas or positive culture for M. tuberculosis (or PCR/GeneXpert) remains the definitive diagnostic gold standard.

7. Risks, Complications, and Contraindications

Risks of Delayed Treatment

  • Fibrous Ankylosis: The knee becomes fixed in a non-functional position.
  • Pathological Subluxation: Destruction of ligaments leads to knee instability.
  • Sinus Tract Formation: Secondary bacterial infection (superinfection) of the sinus tract is a severe complication.
  • Growth Disturbance: In pediatric patients, damage to the epiphyseal plate can cause limb-length discrepancy.

Contraindications

  • Corticosteroids: Intra-articular steroid injections are strictly contraindicated if TB is suspected; they suppress local immunity and accelerate joint destruction.
  • Incomplete Drug Therapy: Sub-therapeutic dosing or premature cessation leads to Multi-Drug Resistant TB (MDR-TB).

8. Management and Prognosis

Pharmacological Management

The standard regimen (DOTS - Directly Observed Treatment, Short-course) typically involves:
* Intensive Phase (2 months): Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol.
* Continuation Phase (4-10 months): Isoniazid and Rifampicin.

Surgical Management

Surgery is reserved for:
1. Debridement/Synovectomy: For patients failing to respond to medical therapy.
2. Abscess Drainage: For large, symptomatic cold abscesses.
3. Arthrodesis/Arthroplasty: In cases of severe, end-stage destruction, joint fusion (arthrodesis) or, rarely, total knee replacement (TKR) may be performed once the infection is eradicated.


9. Frequently Asked Questions (FAQ)

1. Is knee tuberculosis contagious?
No, skeletal tuberculosis is not transmitted through touch. It is a secondary manifestation of an internal infection.

2. Can I continue weight-bearing during treatment?
Generally, no. Immobilization in a brace or cast is often required during the initial stages to prevent deformity and reduce pain.

3. How long does the treatment last?
The minimum course of anti-tubercular therapy (ATT) is 6 to 9 months, though some cases require 12+ months based on clinical progress.

4. Will I need surgery for sure?
Not necessarily. Many cases caught in Stage I or early Stage II respond excellently to medical therapy alone.

5. What is the "Phemister Triad"?
It is a classic radiographic triad for TB arthritis: juxta-articular osteoporosis, peripheral erosions, and narrowing of the joint space.

6. Can total knee replacement be done on a TB knee?
It can be performed, but only after the infection has been clinically and microbiologically cleared for a significant period (often 1-2 years post-ATT completion).

7. Why is muscle atrophy so common in this condition?
The chronic inflammatory process leads to reflex inhibition of the quadriceps muscle, causing rapid wasting.

8. Is there a vaccine for skeletal TB?
The BCG vaccine offers some protection against disseminated TB in children, but it does not provide immunity against adult-onset skeletal TB.

9. How do I know if the medicine is working?
Reduction in ESR/CRP levels, decreased pain, and radiographic evidence of healing (or stabilization) are key indicators.

10. What are the signs of drug resistance?
Failure to show clinical improvement after 3 months of compliant ATT suggests the possibility of drug-resistant strains.


10. Conclusion

Tuberculosis of the right knee is a serious medical condition that demands a high index of clinical suspicion. Because the condition mimics several other joint disorders, clinicians must prioritize early biopsy and synovial analysis to confirm the diagnosis. With the advent of modern anti-tubercular chemotherapy, the prognosis for preserving joint function is excellent if the disease is diagnosed early. However, the orthopedic specialist must remain vigilant, as the transition from a manageable synovitis to end-stage joint destruction can occur rapidly if the patient is non-compliant or the diagnosis is missed. Long-term follow-up is essential to ensure no recurrence and to manage secondary orthopedic complications.

Related Clinical Integration

The management of Tuberculosis of the right knee requires a multidisciplinary approach integrating pharmacological intervention, surgical precision, and long-term orthopedic rehabilitation. Treatment is anchored by systemic antitubercular therapy, such as Rifampicin / ريفامبيسين 600 mg, while diagnostic confirmation often necessitates tissue sampling via an EBUS-TBNA Biopsy Needle (21G / 22G) / إبرة خزعة EBUS-TBNA (21G / 22G). In cases where the infection has caused significant joint destruction or secondary complications, surgical intervention may involve debridement using an Arthroscopic Shaver / Burr / محفار / مثقاب منظار المفصل, or in advanced scenarios, complex reconstructive procedures discussed in Infectious Arthritis: Pathogenesis, Diagnosis, and Surgical Management, Revision Total Knee Arthroplasty: A Comprehensive Surgical Guide, Masterclass in Knee Arthrodesis: Indications, Techniques, and Outcomes, Mastering Revision Total Knee Arthroplasty: Tibial Bone Loss & Advanced Grafting Techniques, Revision Total Knee Arthroplasty: Mastering Tibial Bone Loss with Metal Augments, and [Revision Total Knee Arthroplasty: Mastering Femoral Bone Loss with Augments and Allografts](https://www.hutaifortho.com/en/hub/knee/revision-total-knee-arthro

Treatment & Management Options

Share this guide: